UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

The New England journal of medicine, 2007-10, Vol.357 (17), p.1695-1704

2007

Volltextzugriff (PDF)

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4162-4169

2010

Volltextzugriff (PDF)

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1707-1715

2001

Volltextzugriff (PDF)

PD-044: Weekly Versus Three Weekly Cisplatin in Postoperative Chemoradiotherapy for High Risk Head and Neck Cancer

Radiotherapy and oncology, 2013-02, Vol.106, p.S18-S18

2013

Volltextzugriff (PDF)

Different levels of humoral immunoreactivity to different wheat cultivars gliadin are present in patients with celiac disease and in patients with multiple myeloma

BMC immunology, 2009-05, Vol.10 (32), p.32-32, Article 32

2009

Volltextzugriff (PDF)

Decreased oxygen transfer capacity of erythrocytes as a cause of 5-fluorouracil related ischemia

Molecules (Basel, Switzerland), 2008-12, Vol.14 (1), p.53-67

2008

Volltextzugriff (PDF)

Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma

BMC immunology, 2008-05, Vol.9 (1), p.22-22

2008

Volltextzugriff (PDF)

Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor

Vojnosanitetski pregled, 2011-04, Vol.68 (4), p.359-362

2011

Volltextzugriff (PDF)

Abstract 3835: Impaired pSTAT3 and pSTAT5 induction by IL-2 does not affect IFNγ production in NK cells of breast cancer patients

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3835-3835

2010

Volltextzugriff (PDF)

Pharmacological therapy of neuroendocrine tumors

Tumori, 2010-09, Vol.96 (5), p.847

2010

Volltextzugriff (PDF)

Management of hematological complications of malignancy and chemotherapy: The role of hematopoietic growth factors

Archive of oncology, 2004-01, Vol.12 (3), p.177-178

Jelic, Svetislav

2004

Volltextzugriff (PDF)

9. Pharmacological Therapy of Neuroendocrine Tumors

Tumori, 2010-09, Vol.96 (5), p.847-857

2010

Volltextzugriff (PDF)

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

Lung cancer (Amsterdam, Netherlands), 2001-10, Vol.34 (1), p.1-13

2001

Volltextzugriff (PDF)

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC

Clinical & experimental metastasis, 2003-01, Vol.20 (7), p.647-655

2003

Volltextzugriff (PDF)

Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial

Onkologie, 2009-09, Vol.32 (8-9), p.468-1

2009

Volltextzugriff (PDF)

Do clinical trials help us to optimize chemotherapy in the elderly? The lymphoma experience

Archive of oncology, 2002, Vol.10 (3), p.133-135

Jelic, Svetislav

2002

Volltextzugriff (PDF)

Positive serology for Lyme disease Borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?

Hematological oncology, 1999-09, Vol.17 (3), p.107-116

1999

Volltextzugriff (PDF)

Zoledronic acid is more effective than pamidronate for hypercalcemia of malignancy

Evidence-based oncology, 2001, Vol.2 (3), p.159-162

Jelic, Svetislav

2001

Volltextzugriff (PDF)

Treatment of metastatic neck squamous cell carcinomas with unknown primary

Medicinski pregled, 2004-03, Vol.57 (3-4), p.168-170

2004

Volltextzugriff (PDF)

Antibodies contained in “M” component of some patients with multiple myeloma are directed to food antigens?

Leukemia research, 2006-12, Vol.30 (12), p.1585-1586

2006

Volltextzugriff (PDF)

What Is the Best Sequence of Chemotherapy in Advanced Colorectal Cancer? Final Results of a Five-Arm Study

Chemotherapy (Basel), 2006-01, Vol.52 (1), p.20-22

2006

Volltextzugriff (PDF)

Jugular neck dissection for NO neck supraglottic carcinoma

Srpski arhiv za celokupno lekarstvo, 2004, Vol.132 (3-4), p.73-75

2004

Volltextzugriff (PDF)

Advances in systemic treatment of metastatic gastric cancer

Archive of oncology, 2003-01, Vol.11 (3), p.157-159

2003

Volltextzugriff (PDF)

Chemotherapy options for metastatic colorectal carcinoma: First, second, third line

Archive of oncology, 2003-01, Vol.11 (3), p.165-167

2003

Volltextzugriff (PDF)

Code of ethics in science and research good scientific practice

Stomatološki glasnik Srbije, 2007, Vol.54 (2), p.132-140

2007

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(51)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(31)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Female
(24)
Adult
(23)
Aged
(23)
Middle Aged
(23)
Oncology
(22)
Male
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Treatment Outcome
(11)
Antineoplastic Agents
(7)
Tumors
(7)
Breast Neoplasms - Drug Therapy
(6)
Chemotherapy
(6)
Survival Analysis
(6)
Breast Cancer
(5)
Disease-Free Survival
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

PD-044: Weekly Versus Three Weekly Cisplatin in Postoperative Chemoradiotherapy for High Risk Head and Neck Cancer

Different levels of humoral immunoreactivity to different wheat cultivars gliadin are present in patients with celiac disease and in patients with multiple myeloma

Decreased oxygen transfer capacity of erythrocytes as a cause of 5-fluorouracil related ischemia

Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma

Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor

Abstract 3835: Impaired pSTAT3 and pSTAT5 induction by IL-2 does not affect IFNγ production in NK cells of breast cancer patients

Pharmacological therapy of neuroendocrine tumors

Management of hematological complications of malignancy and chemotherapy: The role of hematopoietic growth factors

9. Pharmacological Therapy of Neuroendocrine Tumors

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC

Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial

Do clinical trials help us to optimize chemotherapy in the elderly? The lymphoma experience

Positive serology for Lyme disease Borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?

Zoledronic acid is more effective than pamidronate for hypercalcemia of malignancy

Treatment of metastatic neck squamous cell carcinomas with unknown primary

Antibodies contained in “M” component of some patients with multiple myeloma are directed to food antigens?

What Is the Best Sequence of Chemotherapy in Advanced Colorectal Cancer? Final Results of a Five-Arm Study

Jugular neck dissection for NO neck supraglottic carcinoma

Advances in systemic treatment of metastatic gastric cancer

Chemotherapy options for metastatic colorectal carcinoma: First, second, third line

Code of ethics in science and research good scientific practice

Aktive Filter

Suchergebnisse filtern